CEL SCI director granted 110K options at $1.49
CEL SCI CORP director Robert Eugene Watson reported a grant of 110,000 stock options on 2026-08-14.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
CEL SCI CORP director Robert Eugene Watson reported a grant of 110,000 stock options on 2026-08-14. The options have an exercise price of $1.49 per share, an associated grant value of $0.01 per option, and expire on 2036-08-13. They vest in three equal annual installments starting one year after the grant date and are exercisable for 110,000 shares of common stock. Following this award, Watson holds 137,271 options directly.
Insider Trade Summary
Grant/Award: 110,000 shares
Grant/Award
1 txn
Insider
Watson Robert Eugene
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Options F1 | 110,000 | $0.01 | $1K |
Holdings After Transaction:
Options — 137,271 contracts (Direct)
Footnotes (1)
- F1. The stock options vest in three (3) equal annual installments commencing one year after the grant date.
Key Figures
Options granted: 110,000 options
Grant price per option: $0.0100 per option
Exercise price: $1.4900 per share
+4 more
7 metrics
Options granted
110,000 options
Stock option award to director on 2026-08-14
Grant price per option
$0.0100 per option
Recorded transaction price for the option grant
Exercise price
$1.4900 per share
Price to purchase CEL SCI common stock upon exercise
Underlying shares
110,000 shares
Common shares underlying the newly granted options
Options after transaction
137,271 options
Total options held directly by Watson following the grant
Expiration date
2036-08-13
Expiry of the newly granted options
Vesting schedule
Three equal annual installments
Commencing one year after the grant date per footnote
Key Terms
stock options, exercise price, expiration date, underlying security, +1 more
5 terms
stock options financial
"The stock options vest in three (3) equal annual installments"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
exercise price financial
"conversion_or_exercise_price": "1.4900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-08-13""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
underlying security financial
"underlying_security_title": "Common Stock""
vesting financial
"options vest in three (3) equal annual installments"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity award did CVM director Robert Eugene Watson receive on this Form 4?
Robert Eugene Watson received a grant of 110,000 stock options to purchase CEL SCI CORP common stock. These options were awarded as a derivative security and increase his total direct option holdings to 137,271.
What is the exercise price of the new CEL SCI (CVM) options reported by Robert Eugene Watson?
The new options have an exercise price of $1.49 per share of CEL SCI common stock. This is the price at which Watson can purchase shares when the options are exercised, subject to vesting and expiration terms.
When do Robert Eugene Watson’s new CEL SCI (CVM) options vest?
The options vest in three equal annual installments beginning one year after the grant date. This means one‑third of the 110,000 options will vest each year over three years, assuming continued service through each vesting date.
When do the stock options granted to Robert Eugene Watson at CEL SCI (CVM) expire?
The options expire on 2036-08-13, giving Watson a long-term window to exercise after vesting. After this expiration date, any unexercised options from this grant will no longer be exercisable for CEL SCI common shares.
What is Robert Eugene Watson’s total CEL SCI (CVM) option position after this transaction?
After the reported grant, Watson holds 137,271 options directly. This total includes the newly awarded 110,000 options and represents his reported derivative position in CEL SCI common stock options following the transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
